Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Defects, Congenital | 31 | 2023 | 61 | 7.110 |
Why?
|
Cardiac Surgical Procedures | 27 | 2021 | 48 | 6.280 |
Why?
|
Cardiopulmonary Bypass | 16 | 2020 | 22 | 4.120 |
Why?
|
Hyperglycemia | 5 | 2019 | 53 | 2.500 |
Why?
|
Intensive Care Units, Pediatric | 10 | 2018 | 16 | 2.420 |
Why?
|
Postoperative Complications | 14 | 2021 | 206 | 2.110 |
Why?
|
Length of Stay | 10 | 2023 | 184 | 1.970 |
Why?
|
Heart Ventricles | 11 | 2023 | 121 | 1.960 |
Why?
|
Infant | 39 | 2023 | 1014 | 1.860 |
Why?
|
Inflammation | 5 | 2020 | 577 | 1.550 |
Why?
|
Child | 32 | 2023 | 2875 | 1.530 |
Why?
|
Enteral Nutrition | 2 | 2020 | 16 | 1.410 |
Why?
|
Fontan Procedure | 5 | 2023 | 9 | 1.400 |
Why?
|
Infant, Newborn | 33 | 2023 | 871 | 1.300 |
Why?
|
Nutritional Support | 2 | 2019 | 4 | 1.290 |
Why?
|
Respiration, Artificial | 5 | 2020 | 37 | 1.270 |
Why?
|
Critical Care | 7 | 2023 | 37 | 1.210 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2019 | 8 | 1.170 |
Why?
|
Hypoplastic Left Heart Syndrome | 8 | 2023 | 8 | 1.160 |
Why?
|
Heart Diseases | 4 | 2017 | 99 | 1.120 |
Why?
|
Intensive Care, Neonatal | 2 | 2018 | 12 | 1.120 |
Why?
|
Humans | 82 | 2023 | 34853 | 1.100 |
Why?
|
Insulin Resistance | 2 | 2019 | 177 | 1.060 |
Why?
|
Intensive Care Units | 6 | 2023 | 57 | 0.930 |
Why?
|
Cardiac Output | 5 | 2016 | 19 | 0.850 |
Why?
|
Monitoring, Physiologic | 3 | 2016 | 35 | 0.810 |
Why?
|
Fluid Therapy | 2 | 2018 | 27 | 0.790 |
Why?
|
Postoperative Care | 5 | 2017 | 18 | 0.780 |
Why?
|
Treatment Outcome | 20 | 2023 | 1349 | 0.740 |
Why?
|
Retrospective Studies | 19 | 2023 | 1961 | 0.740 |
Why?
|
Child, Preschool | 16 | 2019 | 1318 | 0.730 |
Why?
|
Calorimetry, Indirect | 2 | 2016 | 9 | 0.680 |
Why?
|
Insulin | 3 | 2020 | 224 | 0.680 |
Why?
|
Registries | 5 | 2019 | 330 | 0.680 |
Why?
|
Blood Glucose | 3 | 2016 | 333 | 0.680 |
Why?
|
Female | 43 | 2023 | 19873 | 0.660 |
Why?
|
Vascular Resistance | 5 | 2016 | 32 | 0.660 |
Why?
|
Nutritional Requirements | 1 | 2018 | 37 | 0.640 |
Why?
|
Critical Illness | 5 | 2018 | 37 | 0.630 |
Why?
|
Magnesium | 1 | 2018 | 95 | 0.630 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 55 | 0.610 |
Why?
|
Physician-Patient Relations | 2 | 2010 | 118 | 0.610 |
Why?
|
Ketones | 1 | 2016 | 17 | 0.580 |
Why?
|
Male | 38 | 2023 | 18870 | 0.580 |
Why?
|
Health Promotion | 2 | 2013 | 588 | 0.570 |
Why?
|
Wounds and Injuries | 1 | 2018 | 166 | 0.570 |
Why?
|
Hospital Mortality | 6 | 2019 | 183 | 0.560 |
Why?
|
Health Expenditures | 2 | 2018 | 30 | 0.540 |
Why?
|
Disease Management | 2 | 2018 | 61 | 0.530 |
Why?
|
Disasters | 1 | 2016 | 64 | 0.520 |
Why?
|
Hemoglobin A | 1 | 2014 | 4 | 0.500 |
Why?
|
Hemolysis | 1 | 2014 | 39 | 0.500 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2014 | 10 | 0.490 |
Why?
|
Mental Disorders | 1 | 2018 | 285 | 0.490 |
Why?
|
Health Care Costs | 2 | 2015 | 69 | 0.490 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 13 | 0.490 |
Why?
|
Glucocorticoids | 5 | 2011 | 80 | 0.490 |
Why?
|
Time Factors | 11 | 2018 | 1681 | 0.480 |
Why?
|
Cost Savings | 1 | 2013 | 14 | 0.480 |
Why?
|
Energy Metabolism | 1 | 2015 | 160 | 0.480 |
Why?
|
Assisted Circulation | 1 | 2013 | 1 | 0.470 |
Why?
|
Primary Prevention | 1 | 2013 | 57 | 0.460 |
Why?
|
Hypoglycemia | 1 | 2013 | 17 | 0.460 |
Why?
|
Fractures, Bone | 2 | 2018 | 51 | 0.460 |
Why?
|
Erythrocyte Transfusion | 3 | 2018 | 18 | 0.440 |
Why?
|
Risk Factors | 14 | 2021 | 3414 | 0.430 |
Why?
|
Adolescent | 14 | 2023 | 5035 | 0.420 |
Why?
|
Nutritional Status | 3 | 2018 | 114 | 0.410 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 152 | 0.400 |
Why?
|
Prospective Studies | 8 | 2021 | 1353 | 0.400 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2010 | 6 | 0.390 |
Why?
|
Efficiency | 1 | 2010 | 17 | 0.390 |
Why?
|
Ultrasonography, Prenatal | 3 | 2020 | 33 | 0.380 |
Why?
|
Age Factors | 5 | 2018 | 1007 | 0.380 |
Why?
|
Heart Failure | 3 | 2019 | 230 | 0.360 |
Why?
|
Heart Transplantation | 3 | 2019 | 43 | 0.360 |
Why?
|
Self Care | 1 | 2010 | 150 | 0.350 |
Why?
|
Ventricular Dysfunction | 2 | 2020 | 4 | 0.340 |
Why?
|
Thrombosis | 3 | 2015 | 61 | 0.330 |
Why?
|
Opioid-Related Disorders | 1 | 2010 | 112 | 0.330 |
Why?
|
Follow-Up Studies | 8 | 2023 | 964 | 0.320 |
Why?
|
Palliative Care | 5 | 2023 | 52 | 0.320 |
Why?
|
Pediatrics | 4 | 2014 | 66 | 0.320 |
Why?
|
Fracture Healing | 1 | 2007 | 3 | 0.310 |
Why?
|
Fibula | 1 | 2007 | 2 | 0.310 |
Why?
|
Ankle Injuries | 1 | 2007 | 3 | 0.310 |
Why?
|
Weight-Bearing | 1 | 2007 | 21 | 0.310 |
Why?
|
Heart | 3 | 2017 | 178 | 0.310 |
Why?
|
Comorbidity | 4 | 2018 | 606 | 0.310 |
Why?
|
Health Status | 1 | 2010 | 356 | 0.310 |
Why?
|
Data Mining | 2 | 2017 | 21 | 0.300 |
Why?
|
Echocardiography | 4 | 2021 | 144 | 0.280 |
Why?
|
Cooperative Behavior | 2 | 2019 | 205 | 0.270 |
Why?
|
Adult | 11 | 2021 | 11034 | 0.270 |
Why?
|
Young Adult | 6 | 2017 | 4012 | 0.270 |
Why?
|
Medical Informatics | 2 | 2023 | 19 | 0.260 |
Why?
|
Self Disclosure | 1 | 2005 | 42 | 0.260 |
Why?
|
Benchmarking | 2 | 2017 | 27 | 0.250 |
Why?
|
Complementary Therapies | 1 | 2005 | 45 | 0.250 |
Why?
|
Aged | 7 | 2018 | 6448 | 0.250 |
Why?
|
Heart-Assist Devices | 2 | 2019 | 16 | 0.250 |
Why?
|
Cohort Studies | 4 | 2019 | 1422 | 0.250 |
Why?
|
Coronary Disease | 1 | 2005 | 113 | 0.240 |
Why?
|
Protein-Losing Enteropathies | 1 | 2023 | 2 | 0.240 |
Why?
|
Multivariate Analysis | 4 | 2013 | 570 | 0.240 |
Why?
|
Communication | 1 | 2005 | 170 | 0.230 |
Why?
|
Methylprednisolone | 4 | 2011 | 13 | 0.230 |
Why?
|
Troponin I | 1 | 2003 | 18 | 0.230 |
Why?
|
Myocardial Reperfusion Injury | 3 | 2014 | 54 | 0.230 |
Why?
|
Calcium-Binding Proteins | 1 | 2003 | 72 | 0.220 |
Why?
|
Ventricular Function, Right | 2 | 2023 | 35 | 0.220 |
Why?
|
Oxygen Consumption | 3 | 2016 | 98 | 0.220 |
Why?
|
Sex Factors | 2 | 2018 | 859 | 0.220 |
Why?
|
Cost-Benefit Analysis | 3 | 2013 | 142 | 0.220 |
Why?
|
Coronary Care Units | 3 | 2016 | 3 | 0.210 |
Why?
|
Middle Aged | 9 | 2018 | 9642 | 0.210 |
Why?
|
Cardiology | 3 | 2005 | 16 | 0.210 |
Why?
|
Carbon Dioxide | 2 | 2016 | 78 | 0.200 |
Why?
|
United States | 10 | 2021 | 3894 | 0.200 |
Why?
|
Myocytes, Cardiac | 1 | 2003 | 165 | 0.200 |
Why?
|
Program Evaluation | 2 | 2013 | 316 | 0.190 |
Why?
|
Smoking | 1 | 2007 | 903 | 0.190 |
Why?
|
Preoperative Care | 6 | 2006 | 25 | 0.190 |
Why?
|
Transposition of Great Vessels | 1 | 2020 | 2 | 0.190 |
Why?
|
Survival Analysis | 4 | 2020 | 322 | 0.180 |
Why?
|
Risk Assessment | 5 | 2017 | 727 | 0.180 |
Why?
|
Oxygen | 2 | 2016 | 193 | 0.180 |
Why?
|
Intraoperative Care | 3 | 2011 | 10 | 0.180 |
Why?
|
Morbidity | 2 | 2019 | 94 | 0.180 |
Why?
|
Logistic Models | 5 | 2019 | 894 | 0.180 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 48 | 0.180 |
Why?
|
Inflammation Mediators | 2 | 2015 | 120 | 0.170 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2019 | 27 | 0.170 |
Why?
|
Homeostasis | 1 | 2020 | 172 | 0.170 |
Why?
|
Heart Arrest | 1 | 2019 | 32 | 0.170 |
Why?
|
Colloids | 1 | 2018 | 17 | 0.170 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2018 | 22 | 0.170 |
Why?
|
Albumins | 1 | 2018 | 24 | 0.170 |
Why?
|
Tacrolimus | 1 | 2018 | 10 | 0.170 |
Why?
|
Vasodilator Agents | 2 | 2013 | 54 | 0.170 |
Why?
|
Organ Transplantation | 1 | 2018 | 17 | 0.170 |
Why?
|
Hypertension, Pulmonary | 3 | 2005 | 77 | 0.170 |
Why?
|
Postoperative Period | 1 | 2018 | 26 | 0.170 |
Why?
|
Graft Rejection | 1 | 2018 | 38 | 0.170 |
Why?
|
Anticoagulants | 2 | 2012 | 97 | 0.160 |
Why?
|
Canada | 2 | 2016 | 121 | 0.160 |
Why?
|
Heart Bypass, Right | 1 | 2018 | 1 | 0.160 |
Why?
|
Odds Ratio | 3 | 2015 | 517 | 0.160 |
Why?
|
Health Care Rationing | 1 | 2017 | 5 | 0.160 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 72 | 0.160 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 33 | 0.160 |
Why?
|
Perioperative Care | 1 | 2017 | 5 | 0.160 |
Why?
|
Causality | 2 | 2023 | 45 | 0.160 |
Why?
|
Decision Support Techniques | 1 | 2017 | 48 | 0.160 |
Why?
|
Energy Intake | 1 | 2018 | 160 | 0.150 |
Why?
|
Databases, Factual | 2 | 2016 | 288 | 0.150 |
Why?
|
Prenatal Care | 1 | 2018 | 74 | 0.150 |
Why?
|
Recovery of Function | 2 | 2016 | 89 | 0.150 |
Why?
|
Linear Models | 2 | 2015 | 253 | 0.150 |
Why?
|
Endocrine System Diseases | 1 | 2016 | 12 | 0.150 |
Why?
|
North America | 2 | 2013 | 60 | 0.150 |
Why?
|
Patient Selection | 1 | 2017 | 154 | 0.140 |
Why?
|
Ebstein Anomaly | 1 | 2016 | 1 | 0.140 |
Why?
|
Anesthesia | 1 | 2016 | 14 | 0.140 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2016 | 13 | 0.140 |
Why?
|
California | 1 | 2018 | 436 | 0.140 |
Why?
|
Basal Metabolism | 1 | 2016 | 6 | 0.140 |
Why?
|
Tricuspid Valve | 1 | 2016 | 13 | 0.140 |
Why?
|
Echocardiography, Doppler | 1 | 2016 | 39 | 0.140 |
Why?
|
Survival Rate | 2 | 2021 | 310 | 0.140 |
Why?
|
Pulmonary Artery | 3 | 2023 | 37 | 0.130 |
Why?
|
Endothelin-1 | 3 | 2005 | 54 | 0.130 |
Why?
|
Interleukin-6 | 1 | 2015 | 140 | 0.130 |
Why?
|
Hospitals, Pediatric | 2 | 2011 | 19 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 233 | 0.120 |
Why?
|
Lower Extremity | 1 | 2014 | 38 | 0.120 |
Why?
|
Ischemic Preconditioning | 1 | 2014 | 48 | 0.120 |
Why?
|
Models, Statistical | 1 | 2015 | 171 | 0.120 |
Why?
|
Calpain | 2 | 2005 | 31 | 0.120 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 1003 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2015 | 255 | 0.120 |
Why?
|
Triiodothyronine | 1 | 2013 | 30 | 0.120 |
Why?
|
Brain Ischemia | 2 | 2006 | 179 | 0.120 |
Why?
|
Euthanasia, Passive | 1 | 2013 | 3 | 0.120 |
Why?
|
Pressure Ulcer | 1 | 2013 | 6 | 0.120 |
Why?
|
Infection Control | 1 | 2013 | 13 | 0.120 |
Why?
|
Neurologic Examination | 1 | 2013 | 31 | 0.120 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 15 | 0.120 |
Why?
|
Vasoconstrictor Agents | 1 | 2013 | 38 | 0.120 |
Why?
|
Cardiotonic Agents | 1 | 2013 | 35 | 0.110 |
Why?
|
Healthcare Disparities | 1 | 2017 | 446 | 0.110 |
Why?
|
Swine | 5 | 2005 | 182 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2013 | 104 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 2 | 2006 | 468 | 0.110 |
Why?
|
Enoxaparin | 1 | 2012 | 3 | 0.110 |
Why?
|
Hemodynamics | 4 | 2016 | 86 | 0.110 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 2561 | 0.110 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 423 | 0.110 |
Why?
|
Data Collection | 3 | 2016 | 188 | 0.110 |
Why?
|
Ontario | 3 | 2020 | 27 | 0.110 |
Why?
|
Blood Preservation | 1 | 2011 | 6 | 0.110 |
Why?
|
Blood Pressure | 1 | 2016 | 613 | 0.100 |
Why?
|
Biomedical Research | 1 | 2016 | 371 | 0.100 |
Why?
|
Warfarin | 1 | 2012 | 59 | 0.100 |
Why?
|
Analysis of Variance | 2 | 2011 | 528 | 0.100 |
Why?
|
Anecdotes as Topic | 1 | 2010 | 5 | 0.100 |
Why?
|
Pennsylvania | 1 | 2010 | 41 | 0.100 |
Why?
|
Employer Health Costs | 1 | 2010 | 1 | 0.100 |
Why?
|
Cost Control | 1 | 2010 | 8 | 0.100 |
Why?
|
Occupational Health | 1 | 2010 | 19 | 0.100 |
Why?
|
Insurance Claim Review | 1 | 2010 | 24 | 0.100 |
Why?
|
Task Performance and Analysis | 1 | 2010 | 32 | 0.100 |
Why?
|
Longitudinal Studies | 1 | 2013 | 841 | 0.100 |
Why?
|
Substance-Related Disorders | 1 | 2018 | 685 | 0.100 |
Why?
|
Health Services | 1 | 2010 | 53 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2010 | 54 | 0.090 |
Why?
|
American Recovery and Reinvestment Act | 1 | 2010 | 1 | 0.090 |
Why?
|
Cause of Death | 1 | 2011 | 154 | 0.090 |
Why?
|
Medical Records Systems, Computerized | 1 | 2010 | 18 | 0.090 |
Why?
|
Speech Recognition Software | 1 | 2009 | 1 | 0.090 |
Why?
|
Interdisciplinary Communication | 1 | 2010 | 34 | 0.090 |
Why?
|
Telephone | 1 | 2009 | 32 | 0.090 |
Why?
|
Stroke | 1 | 2013 | 274 | 0.090 |
Why?
|
Hyperlipidemias | 1 | 2009 | 35 | 0.090 |
Why?
|
Managed Care Programs | 1 | 2009 | 35 | 0.090 |
Why?
|
Internet | 1 | 2010 | 204 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 77 | 0.080 |
Why?
|
Pregnancy | 3 | 2020 | 1503 | 0.080 |
Why?
|
Peroxidase | 2 | 2005 | 50 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2018 | 984 | 0.080 |
Why?
|
Animals | 6 | 2016 | 14307 | 0.080 |
Why?
|
Chronic Disease | 2 | 2010 | 469 | 0.080 |
Why?
|
Rotation | 1 | 2007 | 23 | 0.080 |
Why?
|
Treatment Refusal | 1 | 2007 | 20 | 0.080 |
Why?
|
Medication Adherence | 1 | 2009 | 165 | 0.080 |
Why?
|
Radiography | 1 | 2007 | 75 | 0.080 |
Why?
|
Pulmonary Circulation | 2 | 2004 | 5 | 0.080 |
Why?
|
Gestational Age | 2 | 2018 | 190 | 0.070 |
Why?
|
Infant Mortality | 2 | 2020 | 57 | 0.070 |
Why?
|
Ventricular Function, Left | 2 | 2004 | 104 | 0.070 |
Why?
|
Uracil | 1 | 2005 | 8 | 0.070 |
Why?
|
American Hospital Association | 1 | 2005 | 3 | 0.070 |
Why?
|
Heparin | 1 | 2005 | 34 | 0.070 |
Why?
|
Thrombocytopenia | 1 | 2005 | 21 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2005 | 26 | 0.070 |
Why?
|
Societies, Medical | 1 | 2005 | 62 | 0.070 |
Why?
|
Tidal Volume | 1 | 2005 | 7 | 0.070 |
Why?
|
Attitude to Health | 2 | 2005 | 311 | 0.060 |
Why?
|
Prognosis | 2 | 2018 | 707 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2005 | 53 | 0.060 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2005 | 34 | 0.060 |
Why?
|
Sex Distribution | 1 | 2005 | 212 | 0.060 |
Why?
|
Education, Medical | 1 | 2005 | 97 | 0.060 |
Why?
|
Heart Arrest, Induced | 1 | 2004 | 3 | 0.060 |
Why?
|
Hawaii | 1 | 2010 | 1878 | 0.060 |
Why?
|
Nitrogen | 1 | 2005 | 63 | 0.060 |
Why?
|
Incidence | 2 | 2021 | 882 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2005 | 131 | 0.060 |
Why?
|
Coronary Circulation | 1 | 2003 | 27 | 0.060 |
Why?
|
Anastomosis, Surgical | 1 | 2003 | 22 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2014 | 269 | 0.060 |
Why?
|
Social Class | 1 | 2005 | 228 | 0.060 |
Why?
|
Stroke Volume | 1 | 2023 | 97 | 0.060 |
Why?
|
Premedication | 1 | 2002 | 4 | 0.060 |
Why?
|
Evidence-Based Medicine | 2 | 2018 | 92 | 0.050 |
Why?
|
Behavioral Medicine | 1 | 2002 | 10 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2002 | 37 | 0.050 |
Why?
|
Macrophages | 1 | 2005 | 431 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2002 | 26 | 0.050 |
Why?
|
Hospitalization | 1 | 2005 | 370 | 0.050 |
Why?
|
Patient Readmission | 1 | 2023 | 74 | 0.050 |
Why?
|
Hepatitis C, Chronic | 1 | 2002 | 39 | 0.050 |
Why?
|
Affective Symptoms | 1 | 2002 | 55 | 0.050 |
Why?
|
Antiviral Agents | 1 | 2002 | 148 | 0.050 |
Why?
|
Myocardium | 1 | 2002 | 224 | 0.050 |
Why?
|
Perinatal Care | 1 | 2020 | 15 | 0.050 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 28 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2002 | 287 | 0.040 |
Why?
|
Prevalence | 3 | 2011 | 1425 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2019 | 17 | 0.040 |
Why?
|
Primary Health Care | 1 | 2002 | 283 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2003 | 1442 | 0.040 |
Why?
|
Blood Gas Analysis | 1 | 2018 | 5 | 0.040 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2018 | 5 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2018 | 17 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2018 | 50 | 0.040 |
Why?
|
Consensus | 1 | 2018 | 41 | 0.040 |
Why?
|
Regression Analysis | 2 | 2017 | 429 | 0.040 |
Why?
|
Anemia | 1 | 2018 | 45 | 0.040 |
Why?
|
Hemoglobins | 1 | 2018 | 101 | 0.040 |
Why?
|
Genetic Markers | 1 | 2018 | 118 | 0.040 |
Why?
|
Waiting Lists | 1 | 2017 | 33 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 5 | 0.040 |
Why?
|
Perinatal Mortality | 1 | 2016 | 2 | 0.040 |
Why?
|
Medical Record Linkage | 1 | 2016 | 15 | 0.040 |
Why?
|
Genotype | 1 | 2018 | 641 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 555 | 0.040 |
Why?
|
Ventilator Weaning | 1 | 2015 | 3 | 0.030 |
Why?
|
Pilot Projects | 1 | 2018 | 628 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2015 | 22 | 0.030 |
Why?
|
Electrocardiography | 1 | 2016 | 154 | 0.030 |
Why?
|
Acute Disease | 1 | 2016 | 141 | 0.030 |
Why?
|
Treatment Failure | 1 | 2015 | 65 | 0.030 |
Why?
|
Cerebrovascular Circulation | 2 | 2006 | 71 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 50 | 0.030 |
Why?
|
Graft Survival | 1 | 2015 | 34 | 0.030 |
Why?
|
Michigan | 1 | 2015 | 22 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2016 | 65 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 64 | 0.030 |
Why?
|
New York | 1 | 2015 | 69 | 0.030 |
Why?
|
Apoptosis | 1 | 2002 | 1317 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2016 | 901 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 424 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 195 | 0.030 |
Why?
|
Hypothermia, Induced | 2 | 2005 | 26 | 0.030 |
Why?
|
Hyperthyroidism | 1 | 2013 | 5 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 2013 | 26 | 0.030 |
Why?
|
Administration, Inhalation | 2 | 2005 | 75 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2015 | 608 | 0.030 |
Why?
|
Animals, Newborn | 2 | 2005 | 323 | 0.030 |
Why?
|
Ventricular Function | 1 | 2012 | 8 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2015 | 1056 | 0.030 |
Why?
|
Erythrocyte Count | 1 | 2011 | 11 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 35 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2011 | 31 | 0.030 |
Why?
|
Risk | 1 | 2011 | 256 | 0.020 |
Why?
|
Public Health Informatics | 1 | 2010 | 8 | 0.020 |
Why?
|
Insurance Claim Reporting | 1 | 2009 | 4 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2009 | 73 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2009 | 210 | 0.020 |
Why?
|
Pain | 1 | 1990 | 249 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2005 | 17 | 0.020 |
Why?
|
Shock, Cardiogenic | 1 | 2005 | 9 | 0.020 |
Why?
|
Thymine | 1 | 2005 | 25 | 0.020 |
Why?
|
Chlorides | 1 | 2005 | 52 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2005 | 75 | 0.020 |
Why?
|
Mutagenesis | 1 | 2005 | 87 | 0.020 |
Why?
|
Health Behavior | 1 | 2009 | 491 | 0.020 |
Why?
|
Heme | 1 | 2005 | 69 | 0.020 |
Why?
|
Lung Compliance | 1 | 2005 | 3 | 0.020 |
Why?
|
Aorta | 1 | 2005 | 161 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2005 | 342 | 0.020 |
Why?
|
Temperature | 1 | 2005 | 275 | 0.020 |
Why?
|
Models, Chemical | 1 | 2005 | 201 | 0.020 |
Why?
|
Neutrophil Activation | 1 | 2004 | 3 | 0.020 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2004 | 5 | 0.020 |
Why?
|
Heart Septum | 1 | 2004 | 6 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2004 | 12 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2004 | 70 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2005 | 406 | 0.010 |
Why?
|
Random Allocation | 1 | 2004 | 139 | 0.010 |
Why?
|
Monocytes | 1 | 2005 | 258 | 0.010 |
Why?
|
Interleukins | 1 | 2003 | 28 | 0.010 |
Why?
|
Body Temperature | 1 | 2003 | 39 | 0.010 |
Why?
|
Nicotine | 1 | 2005 | 238 | 0.010 |
Why?
|
Phenotype | 1 | 2005 | 650 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 790 | 0.010 |
Why?
|
DNA | 1 | 2005 | 549 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 145 | 0.010 |
Why?
|
Antioxidants | 1 | 2005 | 386 | 0.010 |
Why?
|
Models, Biological | 1 | 2005 | 642 | 0.010 |
Why?
|
Health Services Research | 1 | 2002 | 133 | 0.010 |
Why?
|
NF-kappa B | 1 | 2004 | 306 | 0.010 |
Why?
|
Lung | 1 | 2004 | 413 | 0.010 |
Why?
|
Mutation | 1 | 2005 | 1023 | 0.010 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2002 | 103 | 0.010 |
Why?
|
Depression | 2 | 2002 | 664 | 0.010 |
Why?
|
Cytokines | 1 | 2004 | 569 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2003 | 1152 | 0.010 |
Why?
|
Quality of Life | 1 | 2002 | 459 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2002 | 628 | 0.010 |
Why?
|
Hypertension | 1 | 2002 | 770 | 0.010 |
Why?
|
MMPI | 1 | 1990 | 5 | 0.010 |
Why?
|
Frustration | 1 | 1990 | 6 | 0.010 |
Why?
|
Anger | 1 | 1990 | 20 | 0.010 |
Why?
|
Pain Measurement | 1 | 1990 | 161 | 0.010 |
Why?
|
Fear | 1 | 1990 | 234 | 0.000 |
Why?
|
Anxiety | 1 | 1990 | 705 | 0.000 |
Why?
|